BRPI0820902A2 - Processo para produção de ácidos benzoicos de cicloalquilcarboxamidopiridina - Google Patents

Processo para produção de ácidos benzoicos de cicloalquilcarboxamidopiridina

Info

Publication number
BRPI0820902A2
BRPI0820902A2 BRPI0820902-2A BRPI0820902A BRPI0820902A2 BR PI0820902 A2 BRPI0820902 A2 BR PI0820902A2 BR PI0820902 A BRPI0820902 A BR PI0820902A BR PI0820902 A2 BRPI0820902 A2 BR PI0820902A2
Authority
BR
Brazil
Prior art keywords
cycloalkylcarboxamidopyridine
production
benzoic acids
benzoic
acids
Prior art date
Application number
BRPI0820902-2A
Other languages
English (en)
Inventor
David Siesel
Original Assignee
Vertex Pharmaceuticals Incorporarted
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharmaceuticals Incorporarted filed Critical Vertex Pharmaceuticals Incorporarted
Publication of BRPI0820902A2 publication Critical patent/BRPI0820902A2/pt
Publication of BRPI0820902B1 publication Critical patent/BRPI0820902B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/08Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
BRPI0820902-2A 2007-12-07 2008-12-04 Processo para produção de ácidos benzoicos de cicloalquilcarboxamido-piridina e composto BRPI0820902B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1218107P 2007-12-07 2007-12-07
US61/012,181 2007-12-07
US10957308P 2008-10-30 2008-10-30
US61/109,573 2008-10-30
PCT/US2008/085458 WO2009076142A2 (en) 2007-12-07 2008-12-04 Processes for producing cycloalkylcarboxiamido-pyridine benzoic acids

Publications (2)

Publication Number Publication Date
BRPI0820902A2 true BRPI0820902A2 (pt) 2015-06-23
BRPI0820902B1 BRPI0820902B1 (pt) 2026-01-21

Family

ID=

Also Published As

Publication number Publication date
RS55360B1 (sr) 2017-03-31
PL2639224T3 (pl) 2017-02-28
IL226411A (en) 2014-11-30
MX2010006183A (es) 2010-10-15
RS55298B1 (sr) 2017-03-31
US9776968B2 (en) 2017-10-03
HRP20170851T1 (hr) 2017-08-25
PL2639222T3 (pl) 2017-02-28
EP2639223B1 (en) 2017-03-29
MX364936B (es) 2019-05-15
IL226411A0 (en) 2013-06-27
HK1199019A1 (en) 2015-06-19
HUE031871T2 (en) 2017-08-28
NZ612635A (en) 2015-06-26
PT2639224T (pt) 2016-12-01
KR101612009B1 (ko) 2016-04-12
PL2231606T3 (pl) 2013-07-31
WO2009076142A2 (en) 2009-06-18
IL226410A (en) 2014-07-31
CA2707494A1 (en) 2009-06-18
MX365732B (es) 2019-06-12
EP2231606B1 (en) 2013-02-13
CA2707494C (en) 2018-04-24
US8124781B2 (en) 2012-02-28
ES2604178T3 (es) 2017-03-03
DK2231606T3 (da) 2013-05-13
EP2639222B1 (en) 2016-08-31
JP5702149B2 (ja) 2015-04-15
CN101910134A (zh) 2010-12-08
KR20100101132A (ko) 2010-09-16
LT2639223T (lt) 2017-06-26
DK2639223T3 (en) 2017-06-19
CY1118310T1 (el) 2017-06-28
NZ585794A (en) 2012-05-25
RS52759B (sr) 2013-08-30
EA201070700A1 (ru) 2011-06-30
MX364935B (es) 2019-05-15
EP2639222A1 (en) 2013-09-18
HUE032268T2 (en) 2017-09-28
JP2016026233A (ja) 2016-02-12
CN101910134B (zh) 2014-03-19
CL2010000631A1 (es) 2011-04-01
EP2639224A1 (en) 2013-09-18
JP5797726B2 (ja) 2015-10-21
CA3147290A1 (en) 2009-06-18
US20090176989A1 (en) 2009-07-09
AU2008335440A1 (en) 2009-06-18
CY1113985T1 (el) 2016-07-27
US20160200712A1 (en) 2016-07-14
EP2639223A1 (en) 2013-09-18
CN103864678A (zh) 2014-06-18
HUE029775T2 (en) 2017-04-28
WO2009076142A3 (en) 2009-09-24
HRP20161543T1 (hr) 2017-01-13
US20170158676A9 (en) 2017-06-08
LT2639224T (lt) 2016-10-25
ZA201003624B (en) 2011-08-31
EP2231606A2 (en) 2010-09-29
HRP20130418T1 (en) 2013-06-30
CA2989620A1 (en) 2009-06-18
CY1118332T1 (el) 2017-06-28
KR20160043147A (ko) 2016-04-20
SI2639224T1 (sl) 2016-12-30
IL206205A (en) 2014-04-30
US20140121379A1 (en) 2014-05-01
KR101674404B1 (ko) 2016-11-09
ES2625957T3 (es) 2017-07-21
ES2406940T3 (es) 2013-06-10
PT2231606E (pt) 2013-05-17
CY1118992T1 (el) 2018-01-10
JP2011506332A (ja) 2011-03-03
IL206205A0 (en) 2010-12-30
PT2639222T (pt) 2016-11-01
SI2231606T1 (sl) 2013-06-28
US9321725B2 (en) 2016-04-26
SI2639222T1 (sl) 2016-12-30
SI2639223T1 (sl) 2017-07-31
LT2639222T (lt) 2016-12-12
IL226412A (en) 2014-07-31
ES2604555T3 (es) 2017-03-07
US20120190856A1 (en) 2012-07-26
JP2014043469A (ja) 2014-03-13
DK2639224T3 (en) 2016-10-17
NZ599684A (en) 2013-08-30
HK1146820A1 (en) 2011-07-15
AU2008335440B2 (en) 2013-11-07
PT2639223T (pt) 2017-05-08
CA2989620C (en) 2022-05-03
JP2015044854A (ja) 2015-03-12
PL2639223T3 (pl) 2017-09-29
HRP20161572T1 (hr) 2016-12-30
EP2639224B1 (en) 2016-08-24
DK2639222T3 (en) 2016-10-03
IL226412A0 (en) 2013-06-27
CA3147290C (en) 2026-03-17
KR20150066608A (ko) 2015-06-16
US8592602B2 (en) 2013-11-26
CN103864678B (zh) 2016-05-11
IL226410A0 (en) 2013-06-27
RS56083B1 (sr) 2017-10-31

Similar Documents

Publication Publication Date Title
PT2639222T (pt) Processo de produção de ácidos cicloalquilcarboxamido-piridina-benzoicos
BRPI0923180A2 (pt) processo para a produção de produtos químicos
BRPI0820238A2 (pt) Processo de produção de ácido tereftálico e respectivas composições
BRPI0914917A2 (pt) processo para a produção de ácidos carboxílicos livres.
BRPI0910916A2 (pt) Processo para a produção de um dianidroaçúcar
BRPI0720070A2 (pt) Processo para produção de produtos de tecido
BRPI0814291A2 (pt) Processo para produção de alcoóis
BRPI0915572A2 (pt) processo para a fabricação de epicloroidrina
BRPI1012370A2 (pt) processo para a produção de olefinas
BRPI0819659A2 (pt) Processo para produção de álcool
BRPI0909655A2 (pt) Processo para a preparação regioseletiva de derivados de ácido 1-alquil-3-haloalquil-pirazol-4carboxílico
BRPI0913067A2 (pt) Processo para preparação de l-aminoácidos
BRPI0909368A2 (pt) processo contínuo para a fabricação de alcanolamidas de ácido graxo
BR112012000209A2 (pt) processo para a produção de heterodímeros de ácido glutâmico
BRPI0917984A2 (pt) processo em batelada para a produção de poliamidas
BRPI0817747A2 (pt) Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico
BRPI0910730A2 (pt) processo para a produção e purificação de fases aquosas
BRPI1014812A2 (pt) Processo para a produção de alacoóis
BR112012014490A2 (pt) processo para a preparação substituída de 1-o-acil-2-desóxi-2-fluoro-4-tio-beta-d-arabinofuranoses
BRPI0915441A2 (pt) processo para a produção de escória de espuma
BRPI0813960A2 (pt) Processo para produção de biarilas
BRPI0908900A2 (pt) processo para a produção de polióis
BR112012001274A2 (pt) processo para produção de ácidos decancarboxílicos
BRPI0907872A2 (pt) Processo para produção de ácido dicarboxílico
BRPI0920689A2 (pt) processo para produção de cumeno

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/12/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.